by Jessica Casebolt | May 23, 2023 | Opioid/Substance Use Disorders, Tea Leaves
The Biden administration called on Congress Monday to pass a bill aimed at tackling fentanyl trafficking in the U.S., which would see the synthetic opioid raised to the highest classification of illegal drugs. The bill would permanently place all fentanyl-related...
by Mindy Klowden | May 22, 2023 | Blog, Latest News, Mental Health & Addiction
According to Mental Health America’s 2023 State of Mental Health report, 21 percent of adults are experiencing a mental illness yet 55 percent of those (equating to more than 28 million Americans) do not receive treatment. Recent data from the Centers for Disease...
by Jessica Casebolt | May 16, 2023 | M&A, Tea Leaves
The U.S. Federal Trade Commission is expected to file a lawsuit as early as Tuesday to block Amgen Inc’s $27.8 billion deal to buy Horizon Therapeutics PLC. Amgen struck a deal last year to buy Horizon to strengthen its rare diseases drugs portfolio. The company...
by Jessica Casebolt | May 16, 2023 | Life Sciences, Tea Leaves
CVS Health is closing down its clinical trials arm just two years after its launch. The company began its collaboration with pharmaceutical companies in 2021 and will shut it down at the end of 2024. To date,CVS Health has worked with more than 30 drugmakers on 50...
Recent Comments